OSU-2S
Modify Date: 2025-09-18 17:30:08
OSU-2S structure
|
Common Name | OSU-2S | ||
|---|---|---|---|---|
| CAS Number | 1351056-65-9 | Molecular Weight | 335.532 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H37NO2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of OSU-2SA non-immunosuppressive FTY720 analogue, PKCδ activator with higher antiproliferative potency with IC50 of 2.4, 2.4, and 3.5 uM in Huh7, Hep3B, and PLC5 cells, respectively; exhibited higher in vitro antiproliferative efficacy relative to FTY720 against HCC cells without cytotoxicity in normal hepatocytes, although devoid of S1P1 receptor activity; induces caspase-dependent apoptosis through ROS-dependent PKCδ activation in HCC tumor cells. |
| Name | OSU-2S |
|---|
| Description | A non-immunosuppressive FTY720 analogue, PKCδ activator with higher antiproliferative potency with IC50 of 2.4, 2.4, and 3.5 uM in Huh7, Hep3B, and PLC5 cells, respectively; exhibited higher in vitro antiproliferative efficacy relative to FTY720 against HCC cells without cytotoxicity in normal hepatocytes, although devoid of S1P1 receptor activity; induces caspase-dependent apoptosis through ROS-dependent PKCδ activation in HCC tumor cells. |
|---|---|
| References | References 1. Omar HA, et al. Hepatology. 2011 Jun;53(6):1943-58. 2. Mani R, et al. Leukemia. 2015 Feb;29(2):346-55. 3. Mani R, et al. Exp Hematol. 2015 Sep;43(9):770-4.e2. 4. Omar HA, et al. Front Pharmacol. 2016 Nov 30;7:463. eCollection 2016. View Related Products by Target PKC |
| Molecular Formula | C21H37NO2 |
|---|---|
| Molecular Weight | 335.532 |
| InChIKey | MDUCYXCGWGNEMH-NRFANRHFSA-N |
| SMILES | CCCC(N)(CO)CCc1ccc(OCCCCCC(C)C)cc1 |